As of May 8, 2019, Canadian Blood Services (CBS) has declared an Amber Phase Blood Shortage Advisory impacting the subcutaneous immunoglobulin (SCIg) product, Cuvitru®. Intravenous immunoglobulin (IVIg) products are in adequate supply.
SHA Memo
CBS Shortage Advisory